All In Biotech

Drug Trial Radar · NCT07363590

A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)

A Dose Escalation Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-1045 in Participants With Systemic Lupus Erythematosus and Rheumatoid Arthritis

Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

21

Planned (sponsor's estimate)

Start

Feb 19, 2026

Primary completion

Jul 16, 2029

Study completion Jul 16, 2029

Sponsor

Lead sponsor
Merck Sharp & Dohme LLCMerck & Co. (MRK)
Sponsor type
Industry
First posted
Jan 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study looks at a study medicine called MK-1045 in people with lupus and rheumatoid arthritis (RA). The main goal of the study is to learn about the safety of MK-1045 and if people tolerate it when they receive it at different dose levels (amounts).

Conditions

  • Systemic Lupus Erythematosus
  • Rheumatoid Arthritis

Interventions

  • MK-1045Biological

    IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part 1: Number of Participants with One or More Adverse Events (AEs)Time frame: Up to approximately 12 weeks
  2. Part 1: Number of Participants who Discontinue Study Drug Due to an AETime frame: Up to approximately 4 weeks
  3. Part 2 and Part 3: Number of Participants with One or More AEsTime frame: Up to approximately 52 weeks
  4. Part 2 and Part 3: Number of Participants who Discontinue Study Drug Due to an AETime frame: Up to approximately 2 weeks

Locations

21 sites in 11 countries. Site status is shown where the registry gives one.

  • Gold Coast University Hospital ( Site 1601)

    Southport, Queensland, Australia · Recruiting

  • Anima Diepenbeek ( Site 0601)

    Diepenbeek, Limburg, Belgium · Recruiting

  • UZ Gent ( Site 0602)

    Ghent, Oost-Vlaanderen, Belgium · Recruiting

  • Chinese Academy of Medical Science Peking Union Medical College Hospital ( Site 1501)

    Beijing, Beijing Municipality, China · Recruiting

  • The First Affiliated Hospital of Henan University of Science &Technology ( Site 1502)

    Luoyang, Henan, China · Recruiting

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 1504)

    Wuhan, Hubei, China · Recruiting

  • Renji Hospital Shanghai Jiao Tong University School of Medicine ( Site 1505)

    Shanghai, Shanghai Municipality, China · Recruiting

  • Clinica de la Costa S.A.S. ( Site 0101)

    Barranquilla, Atlántico, Colombia · Recruiting

  • Oncomédica S.A.S ( Site 0103)

    Montería, Departamento de Córdoba, Colombia · Recruiting

  • Fundacion Valle del Lili ( Site 0102)

    Cali, Valle del Cauca Department, Colombia · Recruiting

  • Arensia Exploartory Medicine ( Site 1301)

    Tbilisi, Georgia · Recruiting

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 1901)

    Roma, Italy · Recruiting

  • Istituto Clinico Humanitas- IRCCS ( Site 1902)

    Rozzano, Milano, Italy · Recruiting

  • The University of Tokyo Hospital ( Site 0301)

    Bunkyo, Tokyo, Japan · Active not recruiting

  • Keio University Hospital ( Site 0302)

    Shinjyuku, Tokyo, Japan · Recruiting

  • PMSI Republican Clinical Hospital "T.Mosneaga" ( Site 1001)

    Chisinau, Moldova · Recruiting

  • Clinica San Juan Bautista ( Site 0203)

    Lima, Peru · Recruiting

  • ARENSIA Clinics ( Site 0902)

    Bucharest, Bucharest, Romania · Recruiting

  • ARENSIA Exploratory Medicine-Country Emergency Hospital- Arensia,Cluj-Napoca ( Site 0901)

    Cluj-Napoca, Cluj, Romania · Recruiting

  • Chulalongkorn University ( Site 0501)

    Pathumwan, Bangkok, Thailand · Recruiting

  • Ramathibodi Hospital ( Site 0503)

    Ratchathewi, Bangkok, Thailand · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.